Update on Recast of IVD Directive
|
|
- Dora Horton
- 6 years ago
- Views:
Transcription
1 Update on Recast of IVD Directive IVD Classification In-house Assays EU Reference Laboratories C M Nübling, PEI
2 Concerns identified by the European Commission in the Medical Devices Roadmap ( )... The key elements to the framework are Market Surveillance, Vigilance, Notified Bodies, Clinical Evaluation and Transparency. These areas have suffered in terms of coherence and uniformity of approach in particular due to the lack of efficient coordination between the Member States.... New and emerging technologies have challenged the current framework, highlighting gaps or pointing to potential loopholes including the scarcity of expertise needed to independently assess such technologies. The framework needs to fill these gaps and be made more robust to future technologies.
3 Considerations of the European Commmission in the Medical Devices Roadmap ( )... Ensuring uniform high standards and criteria for the conformity assessment by notified bodies, in particular as regards the assessment of the manufacturer's clinical evaluation and in the field of new technologies... Alignment of the classification of IVDs with GHTF guidance
4 Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on in vitro diagnostic medical devices proposal published September 2012 Regulation is direct European Law will replace IVD Directive 98/79/EC proposal out for comments different Working Groups (CoE, EP) define details and introduce further modifications
5 Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on in vitro diagnostic medical devices Notified Bodies Identification, traceability of devices Clinical evidence Vigilance, Market Surveillance IVD Classification In-house Assays EU Reference Laboratories
6 IVD Classification Class Health Risk Examples individual public A low low B moderate low C high moderate D high high Clinical chemistry analyser, selective culture media Vitamin B12, pregnancy self testing, anti-nuclear antibody, urine test strips Blood glucose self testing, HLA typing, PSA, Rubella, HIV VL, companion IVDs HIV blood donor screening, HIV diagn., ABO, Rhesus
7 Regulatory Requirements high IVD Classification Notified Body Reference Laboratory Batch Verification Notified Body QM System low IVD Class A B C D
8 Annex VII, Classification Criteria risk based classification rules higher flexibility with unforeseen markers past experience with inclusion of vcjd tests into Annex II List A global harmonisation
9 Products of Class D Article 4: in-house developed assays of class D markers are excluded from in-house privilege In different countries, modified (e.g. extraction) NAT systems or quantitave NATs have been successfully validated for blood screening Not all class D markers are covered by CE-marked assays (e.g. HIV-2 screening or diagnostic NATs) Rule 1: Screening, confirmatory and supplemental assays used for blood-, tissue- and organ-transmissible agents In practice, quantitative NAT assays for class D markers (e.g. HIV-1 NAT) often used for screening and/or confirmation of an infection
10 Reference Laboratories for Class D devices Article 78, Tasks Verify CTS compliance Tests on manufactured samples (batch testing) Scientific and technical advice European Commission Member States Notified Bodies Advice regarding state of the art
11 Reference Laboratories Article 78, Tasks Network of Reference Laboratories Development of testing methods for conformity assessment procedures and market surveillance Collaboration with Notified Bodies Recommendations on reference materials and reference measurement procedures Development of standards at international level Scientific opinions to Notified Bodies
12 Article 78, Tasks of Reference Laboratories (2e)...set up and manage a network of national Reference Laboratories...
13 Conclusions (1) Proposed Regulation on IVDs is an important improvement compared to the Directive 98/79/EC Classification Rules appear more flexible than Annex II Lists A, B of Directive 98/79/EC Rules do not always represent real practice of IVD use In-house exemption should be made possible for class D markers, too
14 Conclusions (2) Reference Laboratories following uniform evaluation and assessment schemes may be an important tool to guarantee IVD quality Tasks and modalities of batch testing need further clarification Structure of Reference Laboratory Network Concept of re-evaluations should be included Commission proposal has been published Modifications proposed by various stakeholders under discussion
Update on Regulatory Environment- Europe Experience with 2007/47/EC M5 & Discussions on Possible Recast of EU Medical Device Regulations
Update on Regulatory Environment- Europe Experience with 2007/47/EC M5 & Discussions on Possible Recast of EU Medical Device Regulations Paul Brooks Vice President Healthcare, Americas Presentation to:
More informationClassification under the IVD Regulation
Classification under the IVD Regulation Nick Baker Head of IVD Notified Body LRQA Ltd Improving performance, reducing risk IVD regulation shift in regulatory scrutiny Under the current IVD directive 10-15%
More informationFlexible, robust solutions from BSI. An In Vitro Diagnostic Notified Body. Expertise and experience. IVD regulatory solutions
Flexible, robust solutions from BSI An In Vitro Diagnostic Notified Body Expertise and experience IVD regulatory solutions Updated May 2017 Your guide to the In Vitro Diagnostic Directive The purpose of
More informationUpdate on the IVDR. Sue Spencer
Update on the IVDR Sue Spencer Caution The new regulations are draft the principles have now been agreed but the Annexes are subject to minor changes Further details will be added later pre and post application
More informationIVD Regulation 2017/746
IVD Regulation 2017/746 Dr. Anne Van Nerom Famhp 2017-06-13 Recast-symposium Auditorium Storck (Eurostation II) Rue Juliette Wytsmanstraat 14 1050 Brussels Belgium T +32 2 642 51 11 F +32 2 642 50 01 email:
More informationVerification of Manufactured Products for the IVD Directive
Chapter: 2.5.4 Conformity assessment procedures; Verification of manufactured products Text: Key words: Annex IV-6 and Annex VII-5: In the case of devices covered by Annex II, List A, the manufacturer
More informationHOW TO APPLY FOR MEDICAL DEVICE REGISTRATION UNDER MEDICAL DEVICE ACT 2012 (ACT 737)
MDA/GL No 1: July 2013 Guidelines for implementation of medical device regulatory system HOW TO APPLY FOR MEDICAL DEVICE REGISTRATION UNDER MEDICAL DEVICE ACT 2012 (ACT 737) [Appendix 4 Schedule 3 Medical
More informationMEDICAL DEVICE GUIDANCE
Effective from 1 January 2013 MEDICAL DEVICE GUIDANCE GN-15: Guidance on Medical Device Product Registration Revision 5 CONTENTS 1. INTRODUCTION... 4 1.1. Scope... 5 1.2. Definitions... 5 2. RISK CLASSIFICATION
More informationINDUSTRY S VIEW ON THE FUTURE OF IN VITRO DIAGNOSTIC (IVD) LEGISLATION IN EUROPE. May 2013 SPECIAL REPRINT. By Jesús Rueda Rodríguez, EDMA
May 2013 SPECIAL REPRINT INDUSTRY S VIEW ON THE FUTURE OF IN VITRO DIAGNOSTIC (IVD) LEGISLATION IN EUROPE By Jesús Rueda Rodríguez, EDMA Reproduced with the kind permission of Global Regulatory Press from
More informationGENERAL AND ORGANISATIONAL REQUIREMENTS
NBOG working document applicable for MDR and IVDR WD 2017-1 Draft list of documents to be submitted in the application for designation as a notified body under Regulation (EU) 2017/745 and Regulation (EU)
More informationGood morning ladies and gentlemen, Thank you for inviting me to talk about the IVD industry.
Good morning ladies and gentlemen, Thank you for inviting me to talk about the IVD industry. We are entering a new era of much needed regulatory oversight which might seem a daunting task at first. I am
More informationThe New EU IVDR. Overview of the Main Changes & Clinical Data Requirements. Advance Regulatory Consulting Ltd.
Overview of the Main Changes & Clinical Data Requirements Advance Regulatory Consulting Ltd. : Timeline: Entry in to force Q2 (Apr) 2017 Adoption: +6m NB s apply for designation IVDs classified as Class
More informationUpdated EU Medical Device Regula2ons: What s In, What s Out, and What s Hot?
Updated EU Medical Device Regula2ons: What s In, What s Out, and What s Hot? Introduc2on EU Medical Device Overview Current Medical Device Direc2ves ü Governed by 3 directives (past 15-20 yrs): Polling
More information-Regulation (EC) No.1394/2007 -Regulation (EC) No. 668/2009
Introduction to Advanced Therapy Medicinal Products Regulation -Regulation (EC) No.1394/2007 -Regulation (EC) No. 668/2009 -Directive 2009/120/EC Dr. Maura O Donovan F.R.C.O.G. MA MD M.R.C.P.I. CAT member
More informationMedical Device Regulatory Framework 9 SEPTEMBER 2015 FUNDISA CONFERENCE JANE ROGERS
Medical Device Regulatory Framework 9 SEPTEMBER 2015 FUNDISA CONFERENCE JANE ROGERS Key Topics Definitions Essential Principles Classification Conformity Assessment Framework License to Manufacture, Import,
More informationCAMD Implementation Taskforce
CAMD Implementation Taskforce Medical Devices Regulation/In-vitro Diagnostics Regulation (MDR/IVDR) Roadmap Overview and proposed terms of reference The Competent Authorities for Medical Devices (CAMD)
More informationImplications of the new MDR from a Product Testing and Certification Perspective
Implications of the new MDR from a Product Testing and Certification Perspective Helping You to Access Global Markets FAST and PREDICTABLY www.test-medical-devices.com 1 Hans Gerd Evering MDR - Implications
More informationThe challenges of software medical device regulation.
The challenges of software medical device regulation. david.grainger@mhra.gov.uk Introduction A brief history of software device regulation A look at the new device regulations 2 Current framework In Vitro
More informationTable of Contents. Role of Standards in the Assessment of Medical Devices Study Group 1 Final Document GHTF/SG1/N044:2008
Table of Contents 1.0 Introduction...4 2.0 Rationale, Purpose and Scope...5 2.1 Rationale...5 2.2 Purpose...5 2.3 Scope...5 3.0 References...5 4.0 Definitions...6 5.0 General Principles...7 5.1 Recognition
More informationReady or Not: The New Medical Device Regulations Are Here!
Ready or Not: The New Medical Device Regulations Are Here! Felicia R Cochran, PhD, CMPP TM feliciacochran@earthlink.net FR Cochran 1 General Disclaimers This presentation represents the knowledge, professional
More informationOVERVIEW OF THE PREQUALIFICATION OF IN VITRO DIAGNOSTICS ASSESSMENT
P r e q u a l i f i c a t i o n T e a m - D i a g n o s t i c s OVERVIEW OF THE PREQUALIFICATION OF IN VITRO DIAGNOSTICS ASSESSMENT WHO Prequalification of In Vitro Diagnostics NOTE: Additional technical
More informationGUIDANCE NOTES FOR MANUFACTURERS OF CLASS I MEDICAL DEVICES
MDEG - 2007-12 - II-3.3 MSOGClassIGuidance_Final GUIDANCE NOTES FOR MANUFACTURERS OF CLASS I MEDICAL DEVICES Foreword These guidance notes do not aim to be a definite interpretation of National Laws and/or
More informationGuide for Class I Manufacturers on Compliance with European Communities (Medical Devices) Regulations, 1994
Guide for Class I Manufacturers on Compliance with European Communities (Medical Devices) Regulations, 1994 SUR-G0006-2 27 AUGUST 2010 This guide does not purport to be an interpretation of law and/or
More informationConformity Assessment of Own Brand Labelling
NBRG/306/06 Co-ordination of Title: Chapter: Conformity Assessment of Own Brand Labelling 2.5.5 Conformity assessment for particular product groups Text: Key words: manufacturer means the natural or legal
More informationThis document is meant purely as a documentation tool and the institutions do not assume any liability for its contents
2003R1830 EN 11.12.2008 001.001 1 This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents B REGULATION (EC) No 1830/2003 OF THE EUROPEAN
More informationFINAL DOCUMENT. Global Harmonization Task Force. Title: Clinical Evidence for IVD medical devices Key Definitions and Concepts
GHTF/SG5/N6:2012 FINAL DOCUMENT Global Harmonization Task Force Title: Clinical Evidence for IVD medical devices Key Definitions and Concepts Authoring Group: Study Group 5 of the Global Harmonization
More informationNew Pharmacovigilance legislation. Post-authorisation safety studies. ENCePP Plenary meeting. 3 May 2012
New Pharmacovigilance legislation Post-authorisation safety studies ENCePP Plenary meeting 3 May 2012 Presented by: Annalisa Rubino, PhV and Risk Management, EMA An agency of the European Union Why? Public
More informationThe Pressure Equipment Directive 2014/68/EU. Photo: nostal6ie/ Shutterstock
The Pressure Equipment Directive 2014/68/EU Photo: nostal6ie/ Shutterstock Information for our Customers and Partners. One objective of the EU single market is to ensure the smooth technical transfer of
More informationPROPOSED DOCUMENT. Playbook for Implementation of a Medical Device Regulatory Framework. Authoring Group: AHWP TECHNICAL COMMITTEE (TC) OFFICE BEARERS
AHWPTC/OB/P001:2014 PROPOSED DOCUMENT Title: Playbook for Implementation of a Medical Device Regulatory Framework Authoring Group: AHWP TECHNICAL COMMITTEE (TC) OFFICE BEARERS Date: August 5 th, 2014 This
More informationFirst Annual Biomarker Symposium Quest Diagnostics Clinical Trials
First Annual Biomarker Symposium Quest Diagnostics Clinical Trials Terry Robins, Ph.D. Director Biomarker R&D and Scientific Affairs Quest Diagnostics Clinical Trials Key Considerations: Biomarker Development
More informationThe Top 5 Mistakes in Making a Declaration of Conformity for CE Marking
Intertek Cleeve Road, Leatherhead, Surrey KT22 7SB UK info.uk@intertek.com 01372 370900 www.intertek.com Contents Introduction... 2 The top 5 mistakes in making a Declaration of Conformity... 3 1. Not
More informationPublication as part of the research project Service Potentials in Personalized Medicine
Publication as part of the research project Service Potentials in Personalized Medicine The Changing Regulation of In-Vitro Diagnostic Medical Devices An Evaluation of the European Commission s Recommendation
More informationMedical Device Directive
Medical Device Directive WG9 - IEC/SC 62A ISO/TC 184/SC 2 Joint Working Group 9 Saeed Zahedi 4 th of July 2012 Blatchford Copyright 2012 Commercial in confidence Definition and Requirements MDD is law,
More informationAgenzia Italiana del Farmaco
Agenzia Italiana del Farmaco European Regulation on Advanced Therapies Cristina Pintus Head of European Relations Unit and Coordinator of the Advanced Therapy Project Italian Medicines Agency Proposal
More informationConformity Assessments
Industry support for effective compliance BTHA Toy Safety Directive Guidance 2009/48/EC Conformity Assessments 8 Primary Authority Assurance Milton Keynes Council (MKC) has assured this BTHA guidance as
More informationSAMPLE. Evaluation of Total Analytical Error for Quantitative Medical Laboratory Measurement Procedures
2nd Edition EP21 Evaluation of Total Analytical Error for Quantitative Medical Laboratory Measurement Procedures This guideline provides manufacturers and end users with an understanding of concepts related
More informationDangers of Over-Regulation (or Under- Regulation) of Genetic Testing at EU level. David Barton
Dangers of Over-Regulation (or Under- Regulation) of Genetic Testing at EU level David Barton Department of Clinical Genetics Our Lady s Children s Hospital Dublin Background Diagnostic tests, known as
More informationPost Market Surveillance (including PMCF): common non compliances
Post Market Surveillance (including PMCF): common non compliances Jayanth Katta Ph.D Product Specialist & Certification Manager, General Devices Team, Healthcare 1 Overview EU PMS Requirements for Medical
More informationEuropean Medical Device Regulations (MDR): What To Expect
European Medical Device Regulations (MDR): What To Expect MDQC March 2016 Paul Brooks Senior Vice President Healthcare Solutions Copyright 2015 BSI. All rights reserved. Sources for MDR Update Commission
More informationINSTRUCTIONS FOR CERTIFICATION OF FACTORY PRODUCTION CONTROL
. August 2017 were approved by Manager of Product Certification Bureau of the Polish Register of Shipping on 25 August 2017 Copyright by, 2017. GDAŃSK, AUGUST 2017 1/12 CONTENTS 1. Factory Production Control
More informationEUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL GUIDELINES ON MEDICAL DEVICES
EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL Consumer goods Competitiveness in pharmaceuticals, medical devices, cosmetics MEDDEV. 2.11/1 rev.1 April 2005 GUIDELINES ON MEDICAL DEVICES
More informationMedDev and NB-MED Recommendations
Titel of 2.1 Scope, field of application, explanation of terms Guidelines relating to the application of AIMD and MDD: Definition of medical devices, accessory and manufacturer Guidelines relating to the
More informationWHO Prequalification of In Vitro Diagnostics Programme
P r e q u a l i f i c a t i o n T e a m - D i a g n o s t i c s Information for Manufacturers on the Manufacturing Site(s) Inspection (Assessment of the Quality Management System) WHO Prequalification
More informationCOMMISSION OF THE EUROPEAN COMMUNITIES. Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL
COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 19.6.2002 COM(2002) 319 final 2002/0128(COD) Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on setting standards of quality and
More informationPanel Discussion: European Medical Device Regulations Preparing for the Storm Moderator: Lenita Y. Sims Spears, Senior Quality Consultant/Senior
Panel Discussion: European Medical Device Regulations Preparing for the Storm Moderator: Lenita Y. Sims Spears, Senior Quality Consultant/Senior Regulatory and Compliance Counsel, BioTeknica Panelists:
More informationDi Renzo Regulatory Affairs ROME - MILAN - LONDON
Di Renzo Regulatory Affairs ROME - MILAN - LONDON Di Renzo Regulatory Affairs In 1985, Di Renzo Regulatory Affairs began its regulatory consulting for medicines for human and veterinary use, food and dietary
More informationConformity Assessments Revised Toy Safety Directive 2009/48/EC
Toy Safety Update Conformity Assessments Revised Toy Safety Directive 2009/48/EC Contents 1. Obligations of Economic Operators 2. Introduction 3. Overview 4. How to use this guide 5. The Conformity Assessment
More informationINSTRUCTIONS FOR COMPILATION OF A PRODUCT DOSSIER
P r e q u a l i f i c a t i o n T e a m - D i a g n o s t i c s INSTRUCTIONS FOR COMPILATION OF A PRODUCT DOSSIER Prequalification of In Vitro Diagnostics Programme PQDx_018 v2 30 June 2014 Table of Contents
More informationA Risk-based Approach for In Vitro Companion Diagnostics Device FDA Approval Process Associated with Therapies that have Breakthrough Designation
A Risk-based Approach for In Vitro Companion Diagnostics Device FDA Approval Process Associated with Therapies that have Breakthrough Designation A Risk-based Approach for In Vitro Companion Diagnostics
More informationAAMI Quality Systems White Paper: Comparison of 21 CFR Part 820 to ISO 13485:2016 1
AAMI s White Paper Comparison of 21 CFR Part 820 to ISO 13485:2016 February 2017 AUTHORS Seb Clerkin, GMP Advisory Services Nicola Martin, Owner, Nicola Martin Consulting Jack Ward, Owner, Ward Sciences
More informationNew Biological Reference Materials in 2015 Updated January 2016
New Biological Reference Materials in 2015 Updated January 2016 Part Number Part Description/ Intended use INTERNATIONAL STANDARDS AND REFERENCE PREPARATIONS 13/172 Lupus Anticoagulant (1st International
More informationMEDICAL DEVICE CLINICAL INVESTIGATIONS AND ISO 14155
MEDICAL DEVICE CLINICAL INVESTIGATIONS AND ISO 14155 EXECUTIVE SUMMARY Medical device regulations around the world generally require manufacturers of most types of medical devices to supply data as part
More informationRegulatory Framework in Japan - Past and Future - Building a Regulatory Framework Essential Elements of Compliance / Surveillance
Regulatory Framework in Japan - Past and Future - Building a Regulatory Framework Essential Elements of Compliance / Surveillance Nobuo UEMURA Director Office of Medical Devices III Pharmaceuticals and
More informationRegulations and Directives Past, Present, Future
Regulations and Directives Past, Present, Future Haris Memić, Almir Badnjević and Zijad Džemić Abstract Regulations are binding acts which are obligatory in the European Union. All members of the European
More informationMarket surveillance of medical devices
Market surveillance of medical devices A Joint Action to reinforce public health protection and medical devices monitoring by implementing joint manufacturer inspections and improving clinical process
More informationAdvanced-therapy medicinal products: new competencies in hospital pharmacy Seminar PH4. Relevant Financial Relationships - None
EAHP March 2016 Advanced-therapy medicinal products: new competencies in hospital pharmacy Seminar PH4 Dr. Lenka Taylor Pharmacy University Hospital Heidelberg Disclosure Relevant Financial Relationships
More informationSection I: Pharmaceuticals and Medical Devices
SUPPLEMENT on HEALTHCARE INNOVATION Visionary Goals and Recommendations 51th Japan-U.S. Business Conference Japan-U.S. Business Council / U.S.-Japan Business Council November 14, 2014 The R&D-based pharmaceutical
More informationChanges to the Medical Devices Directive and affect on Manufacturers
TÜV Product Service Ltd Webinar 18 th November 2009 Changes to the Medical Devices Directive and affect on Manufacturers Henry Sibun Manager, Medical & Health Services UK CONTENTS / 1. Introduction 1.
More informationEuropean Parliament resolution of 8 March 2011 on the revision of the General Product Safety Directive and market surveillance (2010/2085(INI))
P7_TA(2011)0076 General product safety and market surveillance European Parliament resolution of 8 March 2011 on the revision of the General Product Safety Directive and market surveillance (2010/2085(INI))
More informationThe In Vitro Diagnostic CRO
The In Vitro Diagnostic CRO Choose Beaufort Because of Our People, Processes and Proven Experience The value of expertise cannot be overstated, especially when it comes to streamlining complicated in vitro
More informationUNANNOUNCED EU MEDICAL DEVICE AUDITS BY NOTIFIED BODIES: IMPACT ON SUPPLIERS
UNANNOUNCED EU MEDICAL DEVICE AUDITS BY NOTIFIED BODIES: IMPACT ON SUPPLIERS Executive Summary European Medicines Agency (EMA) regulations for licensing of medical devices include the use of authorized
More informationProduct Safety and Market Surveillance Package
Product Safety and Market Surveillance Package Prague, 25 September 2013 European Commission The Package: Communication on More Product Safety and Better Market Surveillance in the Single Market Proposal
More informationSelection and use of Ebola in vitro diagnostic (IVD) assays
EMERGENCY GUIDANCE Selection and use of Ebola in vitro diagnostic (IVD) assays June 2015 World Health Organization 2015. All rights reserved. The designations employed and the presentation of the material
More informationReflection paper on co-development of pharmacogenomic biomarkers and Assays in the context of drug development
1 2 3 24 June 2010 EMA/CHMP/641298/2008 Committee for Medicinal Products for Human Use (CHMP) 4 5 6 7 Reflection paper on co-development of pharmacogenomic biomarkers and Assays in the context of drug
More informationBy: Clay Anselmo COO, DLLS, Founder Reglera and Terry J. Dagnon M.S., Vice President Regulatory Affairs, DLSS
AN INTRODUCTION TO THE WORLDWIDE REGULATORY FRAMEWORK FOR MEDICAL DEVICES By: Clay Anselmo COO, DLLS, Founder Reglera and Terry J. Dagnon M.S., Vice President Regulatory Affairs, DLSS COURSE OUTLINE /
More informationTechnical Documentation
Technical Documentation Helga Seiler M.Sc. Vision Science and Business (Optometry) Manager RA Disclaimer 2 The following list of information is not exhaustive The information and views given in the following
More informationIn the huge expanse of Asia, Singapore and
New Medical Device Regulation 16 February 2009 By Ames Gross In the huge expanse of Asia, Singapore and Hong Kong are small places. However, after Japan, they are among the most advanced medical markets
More informationThe European Medical Technology Industry. in figures / 2018
The European Medical Technology Industry in figures / 2018 Table of contents What is Medical Technology? 4 Innovation 10 Employment 14 Companies 18 Expenditure on Medical Technology 20 MedTech Market in
More informationQuestions for quoting
Questions for quoting Please send the completed questionnaire (4 pages) to: TÜV Rheinland LGA Products GmbH Phone: +49 911 655 5225 E-mail: service@de.tuv.com Our locations: Am Grauen Stein D-51105 Köln
More informationGMO Technology Conference
GMO Technology Conference The regulation of Clinical Trials on humans involving therapies containing or consisting of genetically modified organisms The Printworks, Dublin Castle 10 th & 11 th October
More informationFINAL DOCUMENT. International Medical Device Regulators Forum. Medical Device Regulatory Audit Reports
FINAL DOCUMENT International Medical Device Regulators Forum Title: Authoring Group: Medical Device Regulatory Audit Reports IMDRF MDSAP Working Group Date: 2 October 2015 Toshiyoshi Tominaga, IMDRF Chair
More informationPrimary Distribution Activities
Primary Distribution Activities Wholesale Distribution Information Day, Paul Sexton GMP Manager Date Insert on Master Slide Slide 1 Topics What is a Primary Distributor / Wholesaler Special Responsibilities
More informationDue diligence in the European medical devices industry
Due diligence in the European medical devices industry Alison Dennis, Reed Smith LLP www.practicallaw.com/0-205-5707 As the medical devices industry is highly regulated, determining a target company's
More informationCONSTRUCTION SECTOR STANDARDIZATION GUIDANCE DOCUMENT
TF N 548 Rev1 2012-03-29 CONSTRUCTION SECTOR STANDARDIZATION GUIDANCE DOCUMENT How to draft clauses on Assessment and Verification of the Constancy of Performance (AVCP) in harmonized standards for construction
More informationFREQUENTLY ASKED QUESTIONS DURING ELECTRO-MEDICAL DEVICE MARKET ACCESS
FREQUENTLY ASKED QUESTIONS DURING ELECTRO-MEDICAL DEVICE MARKET ACCESS Helping You to Access Global Markets FAST and PREDICTABLY Vishal Thakker, MEng(Hons), AMIMechE Scheme Manager/Product Specialist BSI
More informationGuideline for participating sponsors
Joint pilot project between federal higher authorities and ethics committees for processing of applications for the authorisation of clinical trials on medicinal products for human use in accordance with
More informationApplied Protein Services
Applied Protein Services Applied Protein Services A Window into the Future Development risk and attrition rates remain two of the greatest challenges to a successful biopharmaceutical pipeline. To help
More informationFINAL DOCUMENT. Global Harmonization Task Force (revision of GHTF/SG1/N29:2005)
GHTF/SG1/N071:2012 FINAL DOCUMENT Global Harmonization Task Force (revision of GHTF/SG1/N29:2005) Title: Definition of the Terms Medical Device and In Vitro Diagnostic (IVD) Medical Device Authoring Group:
More informationThe Clean Energy Package
The Clean Energy Package The 5 pillars of the Energy Union Energy Union Security, Solidarity, Trust A fully-integrated Internal Energy Market Energy Efficiency Climate Action Research, Innovation, Competitiveness
More informationThe Clean Energy Package
The Clean Energy Package The 5 pillars of the Energy Union Energy Union Security, Solidarity, Trust A fully-integrated Internal Energy Market Energy Efficiency Climate Action Research, Innovation, Competitiveness
More informationExpert Commentary on BS EN ISO 13485:2016, Medical devices Quality management systems Requirements for regulatory purposes
Expert Commentary on BS EN ISO 13485:2016, Medical devices Quality management systems Requirements for regulatory purposes Author: Eamonn Hoxey, PhD, F.R.Pharm.S., Vice President, Medical Devices Quality
More informationRegulation for Scheme Owners requesting acceptance by ACCREDIA of new Conformity Assessment Schemes and their revisions
Title Reference Regulation for Scheme Owners requesting acceptance by ACCREDIA of new Conformity Assessment Schemes and their revisions RG-19 Revision 00 Date 10-10-2017 NOTE: The present document represents
More informationThe New EU RoHS Directive: Key Topics Under Review
: Key Topics Under Review Written By: James Calder, Manager Global Services July 6, 2010 Intertek 100-505 March Road, Kanata, ON K2K 3A4 rohs@intertek.com +1 613.599.4321 www.intertek.com/rohs Table of
More informationTUV SUD BABT PRODUCTION QUALITY CERTIFICATION SCHEME
TUV SUD BABT PRODUCTION QUALITY CERTIFICATION SCHEME Copyright TUV SUD BABT 2017 A Certification Body of: Page 1 of 33 Contents AMENDMENT RECORD 3 0. INTRODUCTION 3 1. PRE-CONDITIONS TO SUPPORT PRODUCTION
More informationReview of requirements for immunological medicinal products and their evolution since the start of Community legislation on medicines
www.pei.de Review of requirements for immunological medicinal products and their evolution since the start of Community legislation on medicines Dr. Carmen Jungbäck Paul-Ehrlich Institut, Germany London,
More informationFast decisions instead of delays Quality Control through outstanding design
Fast decisions instead of delays Quality Control through outstanding design We are CustomBiotech from Roche In your operations, behind your decisions, powering your products You are driving a paradigm
More informationDesignation and notification of conformity assessment bodies 1
NBOG s Best Practice Guide applicable for MDR, and IVDR 2017-1 Designation and notification of conformity assessment bodies 1 1 Introduction and scope This document aims to provide guidance to the authorities
More information15868/13 JB/mf 1 DGG 1B
COUNCIL OF THE EUROPEAN UNION Brussels, 11 November 2013 (OR. en) 15868/13 Interinstitutional File: 2013/0253 (COD) EF 216 ECOFIN 988 CODEC 2479 REPORT From: To: Subject: Presidency Council Single Resolution
More informationSupporting CE-Marking Obligations of Our Customers: The Role of the Galvanizer
Supporting CE-Marking Obligations of Our Customers: The Role of the Galvanizer NORDIC GALVANIZERS ANNUAL MEETING 8 MAY 2014 COPENHAGEN MURRAY COOK EXECUTIVE DIRECTOR EUROPEAN GENERAL GALVANIZERS ASSOCIATION
More informationRoche, Roche Molecular Diagnostics and more
, Molecular and more [Monte Wetzel, PhD] Patients have questions. We provide answers. Group Clear focus on Healthcare Innovation with two strong pillars Pharma Pharma Genentech Chugai Molecular Professional
More informationOVERVIEW OF THE PREQUALIFICATION OF MALE CIRCUMCISION DEVICES ASSESSMENT PROCESS
D i a g n o s t i c s a n d L a b o r a t o r y T e c h n o l o g y OVERVIEW OF THE PREQUALIFICATION OF MALE CIRCUMCISION DEVICES ASSESSMENT PROCESS Prequalification of Male Circumcision Devices PQMC_007
More informationWhat is the purpose of this website?
What is the purpose of this website? This website aims to explain: How it is possible for different methods to give different results for the same test on the same patient sample Why it is important to
More informationEBA/CP/2013/12 21 May Consultation Paper
EBA/CP/2013/12 21 May 2013 Consultation Paper Draft Regulatory Technical Standards On Passport Notifications under Articles 35, 36 and 39 of the proposed Capital Requirements Directive Consultation Paper
More information1. Council conclusions on strengthening the balance in the pharmaceutical systems in the EU and its Member States
PRESS 17/6/2016 PRESS RELEASE Council of the European Union 1. Council conclusions on strengthening the balance in the pharmaceutical systems in the EU and its Member States "The Council of the European
More informationVIGILANZA E SORVEGLIANZA POST- COMMERCIALIZZAZIONE
VIGILANZA E SORVEGLIANZA POST- COMMERCIALIZZAZIONE VIGILANZA E SORVEGLIANZA POST-COMMERCIALIZZAZIONE Post-Market Surveillance dal punto di vista dell O.N in vista dei nuovi Regolamenti (MDR/IVDR) Francesco
More informationRules and Regulations on GMO-derived food products in the European Union Lynn Insall UK Food and Drink Federation
Rules and Regulations on GMO-derived food products in the European Union Lynn Insall UK Food and Drink Federation Food Safety Workshop, Cairo, 17 April 2005 About the UK Food and Drink Manufacturing Industry
More informationCE Marking for Medical devices
CE Marking of Medical Devices Bart Mersseman Head of Notified Body SGS Belgium Thursday Octobere 12 th 2017 Vlaamse dag van de CE-markering CE Marking for Medical devices Prologue: Legislation in Europe
More informationREGISTRATION OF MEDICAL DEVICE. SUBMISSION & APPLICATION By IDAMAZURA IDRIS MEDICAL DEVICE AUTHORITY
REGISTRATION OF MEDICAL DEVICE SUBMISSION & APPLICATION By IDAMAZURA IDRIS MEDICAL DEVICE AUTHORITY Medical device: regulated item under the Medical Device Act 2012 (Act 737) and its regulation The objective:
More informationGuide to Scientific and Regulatory Advice for GXP activities
Guide to Scientific and Regulatory Advice for GXP activities ADV-G0019-1 7 OCTOBER 2017 This guide does not purport to be an interpretation of law and/or regulations and is for guidance purposes only.
More information